Optimizing Patient Experience and Clinical Outcomes With Systemic Therapy in RAI-Refractory DTC

Date 28 September 2014
Event ESMO 2014
Session Bayer: Optimizing Treatment Benefits with MKIs: Understanding Who and When to Treat
Topics Anti-Cancer Agents & Biologic Therapy
Thyroid Cancer
Translational Research
Presenter Marcia Brose